Search

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that, following receipt of regulatory approvals, it has completed the previously announced sale of a 30 percent interest in Guangzhou Pharmaceuticals Corporation to its joint venture partner Guangzhou Baiyunshan

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2018 third quarter earnings results at 7 a.m. Eastern time Thursday, 28 June 2018, followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today it will hold a Sell-Side Analyst Event on Tuesday, 22 May in New York City. The event will be hosted by Walgreens Boots Alliance Executive Vice Chairman and CEO Stefano Pessina, Co-Chief Operating Officer Alex Gourlay and

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period. The dividend is payable 12 June 2018 to stockholders of record as of 18 May

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2018, which ended 28 February 2018.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of James Kehoe, recently chief financial officer and board director of Takeda Pharmaceutical Company Limited, as the company’s executive vice president and global chief financial officer, effective June 1

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2018 second quarter earnings results at 7 a.m. Eastern time Wednesday, 28 March 2018, followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time.

DEERFIELD, Ill.---Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced the appointment of Sebastian James as Senior Vice President and President and Managing Director of Boots. He also will be contributing to the Group with involvement in a number of key areas, joining the company in the

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly dividend of 40 cents per share, an increase of 6.7 percent over the year-ago period. The dividend is payable 12 March 2018 to stockholders of record as of 15

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the first quarter of fiscal 2018 which ended 30 November 2017.

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) announced today that Executive Vice Chairman and CEO Stefano Pessina and Co-Chief Operating Officer Alex Gourlay will participate in a fireside chat at the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in

DEERFIELD, Ill.--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announces that it has entered into an agreement to reduce its stake in Guangzhou Pharmaceuticals Corporation, a pharmaceutical wholesaling joint venture in China, following an offer from its joint venture partner Guangzhou